
GC33290
Remetinostat
Also listed as Remetinostat (SHP-141)
Remetinostat (SHP-141) (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma
ChemicalCAS946150-57-8MW323.34FormulaC16H21NO6
- CAS number
- 946150-57-8
- Molecular weight
- 323.34
- Formula
- C16H21NO6
- Solubility
- DMSO : 150 mg/mL (463·91 mM)
- InChIKey
- XDZAHHULFQIBFE-UHFFFAOYSA-N
- Catalogue number
- GC33290
- Brand
- GLPBIO
Computed properties PubChem CID 24875489 · XLogP 2 · TPSA 102 Ų · H-bond donors 2
- XLogP
- 2
- TPSA
- 102 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 11
- Heavy atoms
- 23
SMILES COC(=O)C1=CC=C(C=C1)OC(=O)CCCCCCC(=O)NO
Computed descriptors from PubChem (CID 24875489), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il